Quantum Leap Funding Program
Receive up to $1.2 Million in Government Funding.
As CQDM’s key initiative, the Quantum Leap Funding Program was created to help small-to-medium-sized enterprises (SMEs) and Canadian universities with funding to work on cutting-edge, innovative pharmaceutical research projects with the overall goal of discovering cleaner and more efficient drug options.
Quantum Leap Funding Program
Amount of Funding
- Up to 50-66% funding to a maximum of $1.2 million;
- Funding may consist in a grant and/or investment; and
- Applications exceeding the maximum funding request may be considered on an exceptional basis.
Quantum Leap Funding Program
Eligible Applicants
Applicants may be eligible if they meet the following requirements:
- Small or medium-sized enterprises (SME) in Canada and fewer than 500 employees; and
- Public Research Institutions in Canada.
Quantum Leap Funding Program
Eligible Activities
Projects may be eligible if they meet the following requirements:
- TRL – The technologies of interest can be at any stage of the drug development process and involve a wide range of therapeutic indications;
- Drug discovery research to significantly improve, facilitate and/or accelerate the drug discovery process and the development of safer and more effective drugs;
- Quantum Leap projects are executed in close collaboration and with the expert support and funds of pharmaceutical members;
- Projects are associated with specific deliverables and must be ready for use by CQDM pharmaceutical members upon completion; and
- For scientists, the funded research opens new collaboration opportunities with world-class stakeholders in the industry.
Quantum Leap Funding Program
Program Deadline
Speak with a member of our team about current intakes for this program and other funding programs your business may be eligible for.